Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Genetic association of single nucleotide polymorphisms in dystrobrevin binding protein 1 gene with schizophrenia in a Malaysian population.

Tan GK, Tee SF, Tang PY.

Genet Mol Biol. 2015 May;38(2):138-46. doi: 10.1590/S1415-4757382220140142. Epub 2015 May 1.

2.

Why it is hard to find genes associated with social science traits: theoretical and empirical considerations.

Chabris CF, Lee JJ, Benjamin DJ, Beauchamp JP, Glaeser EL, Borst G, Pinker S, Laibson DI.

Am J Public Health. 2013 Oct;103 Suppl 1:S152-66. doi: 10.2105/AJPH.2013.301327. Epub 2013 Aug 8. Erratum in: Am J Public Health. 2014 Jan;104(1):e5.

3.

Genetic influence on the working memory circuitry: behavior, structure, function and extensions to illness.

Karlsgodt KH, Bachman P, Winkler AM, Bearden CE, Glahn DC.

Behav Brain Res. 2011 Dec 1;225(2):610-22. doi: 10.1016/j.bbr.2011.08.016. Epub 2011 Aug 22. Review.

4.

Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.

Talbot K, Louneva N, Cohen JW, Kazi H, Blake DJ, Arnold SE.

PLoS One. 2011 Mar 1;6(3):e16886. doi: 10.1371/journal.pone.0016886.

5.

Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.

Zhang JP, Burdick KE, Lencz T, Malhotra AK.

Biol Psychiatry. 2010 Dec 15;68(12):1126-33. doi: 10.1016/j.biopsych.2010.09.016.

6.

Database of genetic studies of bipolar disorder.

Piletz JE, Zhang X, Ranade R, Liu C.

Psychiatr Genet. 2011 Apr;21(2):57-68. doi: 10.1097/YPG.0b013e328341a346.

7.

Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.

Karlsgodt KH, Robleto K, Trantham-Davidson H, Jairl C, Cannon TD, Lavin A, Jentsch JD.

Biol Psychiatry. 2011 Jan 1;69(1):28-34. doi: 10.1016/j.biopsych.2010.09.012. Epub 2010 Oct 30.

8.

The effects of a DTNBP1 gene variant on attention networks: an fMRI study.

Thimm M, Krug A, Kellermann T, Markov V, Krach S, Jansen A, Zerres K, Eggermann T, Stöcker T, Shah NJ, Nöthen MM, Rietschel M, Kircher T.

Behav Brain Funct. 2010 Sep 16;6:54. doi: 10.1186/1744-9081-6-54.

9.

Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain.

Okuda H, Kuwahara R, Matsuzaki S, Miyata S, Kumamoto N, Hattori T, Shimizu S, Yamada K, Kawamoto K, Hashimoto R, Takeda M, Katayama T, Tohyama M.

PLoS One. 2010 Jan 19;5(1):e8773. doi: 10.1371/journal.pone.0008773.

10.

A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.

Strohmaier J, Frank J, Wendland JR, Schumacher J, Jamra RA, Treutlein J, Nieratschker V, Breuer R, Mattheisen M, Herms S, Mühleisen TW, Maier W, Nöthen MM, Cichon S, Rietschel M, Schulze TG.

Schizophr Res. 2010 May;118(1-3):98-105. doi: 10.1016/j.schres.2009.12.025. Epub 2010 Jan 18.

11.

Comparing prefrontal gray and white matter contributions to intelligence and decision making in schizophrenia and healthy controls.

Nestor PG, Kubicki M, Nakamura M, Niznikiewicz M, McCarley RW, Shenton ME.

Neuropsychology. 2010 Jan;24(1):121-9. doi: 10.1037/a0016981.

12.

Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia.

Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A, Caltagirone C, Bossù P, McDonald C, Gill M, Corvin AP, Spalletta G.

Neuropsychopharmacology. 2010 Jan;35(2):368-73. doi: 10.1038/npp.2009.140. Epub .

13.

No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample.

Bergen SE, Fanous AH, Kuo PH, Wormley BK, O'Neill FA, Walsh D, Riley BP, Kendler KS.

Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):700-5. doi: 10.1002/ajmg.b.31029.

14.

The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders.

Burdick KE, Gunawardane N, Woodberry K, Malhotra AK.

Cogn Neuropsychiatry. 2009;14(4-5):299-311. doi: 10.1080/13546800902805347. Review.

15.

Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.

Tang J, LeGros RP, Louneva N, Yeh L, Cohen JW, Hahn CG, Blake DJ, Arnold SE, Talbot K.

Hum Mol Genet. 2009 Oct 15;18(20):3851-63. doi: 10.1093/hmg/ddp329. Epub 2009 Jul 19.

16.

Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence.

Sabb FW, Burggren AC, Higier RG, Fox J, He J, Parker DS, Poldrack RA, Chu W, Cannon TD, Freimer NB, Bilder RM.

Neuroscience. 2009 Nov 24;164(1):88-107. doi: 10.1016/j.neuroscience.2009.05.013. Epub 2009 May 18. Review.

17.

DTNBP1 is associated with imaging phenotypes in schizophrenia.

Narr KL, Szeszko PR, Lencz T, Woods RP, Hamilton LS, Phillips O, Robinson D, Burdick KE, DeRosse P, Kucherlapati R, Thompson PM, Toga AW, Malhotra AK, Bilder RM.

Hum Brain Mapp. 2009 Nov;30(11):3783-94. doi: 10.1002/hbm.20806.

18.

Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Cox MM, Tucker AM, Tang J, Talbot K, Richer DC, Yeh L, Arnold SE.

Genes Brain Behav. 2009 Jun;8(4):390-7. doi: 10.1111/j.1601-183X.2009.00477.x. Epub 2009 Feb 11.

19.

The dystrobrevin-binding protein 1 gene: features and networks.

Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z.

Mol Psychiatry. 2009 Jan;14(1):18-29. doi: 10.1038/mp.2008.88. Epub 2008 Jul 29. Review.

20.

Association of a nonsynonymous variant of DAOA with visuospatial ability in a bipolar family sample.

Soronen P, Silander K, Antila M, Palo OM, Tuulio-Henriksson A, Kieseppä T, Ellonen P, Wedenoja J, Turunen JA, Pietiläinen OP, Hennah W, Lönnqvist J, Peltonen L, Partonen T, Paunio T.

Biol Psychiatry. 2008 Sep 1;64(5):438-42. doi: 10.1016/j.biopsych.2008.03.028. Epub 2008 May 7.

Items per page

Supplemental Content

Write to the Help Desk